Advertisement

CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas

  • Takahiro Komori
  • Dai Inoue
  • Yoh Zen
  • Norihide Yoneda
  • Azusa Kitao
  • Kazuto Kozaka
  • Akira Yokka
  • Fumihito Toshima
  • Takashi Matsubara
  • Satoshi Kobayashi
  • Toshifumi Gabata
Hepatobiliary-Pancreas
  • 49 Downloads

Abstract

Objectives

To identify imaging features that assist in discriminating intraductal papillary neoplasms of the bile duct (IPNBs) from papillary cholangiocarcinomas (PCCs).

Methods

This study was approved by the institutional review board. Using the recently proposed histological diagnostic criteria for biliary papillary neoplasms, IPNBs and PCCs were selected from 537 biliary neoplasms consecutively resected in a 12.5-year period. Clinical and imaging features were compared between the two groups.

Results

The histology review identified 19 IPNBs and 48 PCCs, representing an estimated prevalence of IPNBs among biliary neoplasms of 4%. Approximately one half of IPNBs were incidentally found on imaging conducted for other purposes. In terms of tumor location, 15/19 IPNBs (79%) developed in intrahepatic bile ducts, and 41/48 PCCs (85%) in the distal bile duct. Cystic appearance was highly suggestive for IPNBs (p < 0.001). Using these two parameters, 78% of papillary bile duct neoplasms could be classified into IPNBs or PCCs. Other imaging findings favoring IPNBs included frond-like mural nodule, downstream bile duct dilatation, and the lack of abnormal enhancement in the adjacent bile duct. Interestingly, two patients with non-invasive or microinvasive IPNB had undergone abdominal imaging studies > 3 years before, and a retrospective review of the previous images identified small nodular or cystic lesions, suggesting a less progressive nature of IPNBs than currently thought.

Conclusions

Imaging findings useful for discriminating IPNBs from PCCs appear to be tumor location, shape of tumor, appearance of mural nodules, duct dilatation at unaffected duct, and abnormal enhancement of the adjacent bile duct.

Key Points

• Intrahepatic location and cystic dilatation of the affected bile duct are the strong discriminators between IPNBs and PCCs.

• The shape of the mural nodule and appearance of the neighboring bile duct are helpful for distinguishing IPNBs and PCCs.

• The less aggressive behavior of IPNBs compared with PCCs may facilitate less invasive management in patients with IPNB.

Keywords

Bile ducts Tomography, X-ray computed Cholangiocarcinoma 

Abbreviations

CT

Computed tomography

DP

Delayed phase

EP

Early phase

HU

Hounsfield unit

IPMN

Intraductal papillary mucinous neoplasm

IPNB

Intraductal papillary neoplasm of the bile duct

MRI

Magnetic resonance imaging

ROI

Region of interest

Notes

Funding

The authors state that this work has not received any funding.

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Dai Inoue.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• Retrospective

• Case-control study

• Multicenter study

References

  1. 1.
    Chen TC, Nakanuma Y, Zen Y et al (2001) Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology 34:651–658CrossRefPubMedGoogle Scholar
  2. 2.
    Zen Y, Fujii T, Itatsu K et al (2006) Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology 44:1333–1343CrossRefPubMedGoogle Scholar
  3. 3.
    Nakanuma Y, Curado MP, Franceschi S et al (2010) Intrahepatic cholangiocarcinoma. In: Bosman FT, Carbeiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system, 4th edn. IARC, LyonGoogle Scholar
  4. 4.
    Nakanuma Y, Sasaki M, Ishikawa A, Tsui W, Chen TC, Huang SF (2002) Biliary papillary neoplasm of the liver. Histol Histopathol 17:851–861PubMedGoogle Scholar
  5. 5.
    Nagai E, Ueki T, Chijiiwa K, Tanaka M, Tsuneyoshi M (1995) Intraductal papillary mucinous neoplasms of the pancreas associated with so-called “mucinous ductal ectasia”. Histochemical and immunohistochemical analysis of 29 cases. Am J Surg Pathol 19:576–589CrossRefPubMedGoogle Scholar
  6. 6.
    Klöppel G, Kosmahl M (2006) Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? J Hepatol 44:249–250CrossRefPubMedGoogle Scholar
  7. 7.
    Ji Y, Fan J, Zhou J et al (2008) Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas. Histol Histopathol 23:41–50PubMedGoogle Scholar
  8. 8.
    Rocha FG, Lee H, Katabi N et al (2012) Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 56:1352–1360CrossRefPubMedGoogle Scholar
  9. 9.
    Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128:1655–1667CrossRefPubMedGoogle Scholar
  10. 10.
    Nakanuma Y, Jang KT, Fukushima N et al (2018) A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage. J Hepatobiliary Pancreat Sci 25:181–187CrossRefPubMedGoogle Scholar
  11. 11.
    Fujikura K, Fukumoto T, Ajiki T et al (2016) Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas. Histopathology 69:950–961CrossRefPubMedGoogle Scholar
  12. 12.
    Lim JH, Jang KT, Choi D (2008) Biliary intraductal papillary-mucinous neoplasm manifesting only as dilatation of the hepatic lobar or segmental bile ducts: imaging features in six patients. AJR Am J Roentgenol 191:778–782CrossRefPubMedGoogle Scholar
  13. 13.
    Kim JE, Lee JM, Kim SH et al (2010) Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology 257:364–372CrossRefPubMedGoogle Scholar
  14. 14.
    Liu Y, Zhong X, Yan L, Zheng J, Liu Z, Liang C (2015) Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth. Eur Radiol 25:1967–1974CrossRefPubMedGoogle Scholar
  15. 15.
    Park HJ, Kim SY, Kim HJ et al (2018) Intraductal papillary neoplasm of the bile duct: clinical, imaging, and pathologic features. AJR Am J Roentgenol 211:67–75CrossRefPubMedGoogle Scholar
  16. 16.
    Ying S, Ying M, Liang W et al (2018) Morphological classification of intraductal papillary neoplasm of the bile duct. Eur Radiol 28:1568–1578CrossRefPubMedGoogle Scholar
  17. 17.
    Zen Y, Pedica F, Patcha VR et al (2011) Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol 24:1079–1089CrossRefPubMedGoogle Scholar
  18. 18.
    Lim JH, Zen Y, Jang KT, Kim YK, Nakanuma Y (2011) Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects. AJR Am J Roentgenol 197:1111–1120CrossRefPubMedGoogle Scholar
  19. 19.
    Barton JG, Barrett DA, Maricevich MA et al (2009) Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford) 11:684–691CrossRefGoogle Scholar
  20. 20.
    Ohtsuka M, Kimura F, Shimizu H et al (2011) Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol 35:512–521CrossRefPubMedGoogle Scholar
  21. 21.
    Onoe S, Shimoyama Y, Ebata T et al (2014) Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients. Surgery 155:280–291CrossRefPubMedGoogle Scholar
  22. 22.
    Fujikura K, Akita M, Ajiki T, Fukumoto T, Itoh T, Zen Y (2018) Recurrent mutations in APC and CTNNB1 and activated Wnt/beta-catenin signaling in intraductal papillary neoplasms of the bile duct: a whole exome sequencing study. Am J Surg Pathol.  https://doi.org/10.1097/pas.0000000000001155 CrossRefPubMedGoogle Scholar
  23. 23.
    Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW (2000) Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 31:12–17CrossRefPubMedGoogle Scholar
  24. 24.
    Choi SC, Lee JK, Jung JH et al (2010) The clinicopathological features of biliary intraductal papillary neoplasms according to the location of tumors. J Gastroenterol Hepatol 25:725–730CrossRefPubMedGoogle Scholar
  25. 25.
    Jung G, Park KM, Lee SS, Yu E, Hong SM, Kim J (2012) Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct. J Hepatol 57:787–793CrossRefPubMedGoogle Scholar
  26. 26.
    Schlitter AM, Born D, Bettstetter M et al (2014) Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways. Mod Pathol 27:73–86CrossRefPubMedGoogle Scholar
  27. 27.
    Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–797 discussion 797–789CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Salvia R, Fernández-del Castillo C, Bassi C et al (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–685 discussion 685–677CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Tanaka M (2015) International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas. Ann Transl Med 3:286PubMedPubMedCentralGoogle Scholar
  30. 30.
    Tanaka M, Fernández-del Castillo C, Adsay V et al (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12:183–197CrossRefPubMedGoogle Scholar
  31. 31.
    Jin KP, Rao SX, Sheng RF, Zeng MS (2018) Skewness of apparent diffusion coefficient (ADC) histogram helps predict the invasive potential of intraductal papillary neoplasms of the bile ducts (IPNBs). Abdom Radiol (NY).  https://doi.org/10.1007/s00261-018-1716-8

Copyright information

© European Society of Radiology 2018

Authors and Affiliations

  • Takahiro Komori
    • 1
  • Dai Inoue
    • 1
  • Yoh Zen
    • 2
  • Norihide Yoneda
    • 1
  • Azusa Kitao
    • 1
  • Kazuto Kozaka
    • 1
  • Akira Yokka
    • 1
  • Fumihito Toshima
    • 1
  • Takashi Matsubara
    • 1
  • Satoshi Kobayashi
    • 1
    • 3
  • Toshifumi Gabata
    • 1
  1. 1.Department of RadiologyKanazawa University Graduate School of Medical ScienceKanazawaJapan
  2. 2.Department of Diagnostic PathologyKobe University HospitalKobeJapan
  3. 3.Department of Quantum Medical ImagingKanazawa University Graduate School of Medical SciencesKanazawaJapan

Personalised recommendations